162 related articles for article (PubMed ID: 37144504)
1. Anti‑tumor properties of FoxO1 in YD‑9 oral squamous cell carcinoma cells.
Kim YG; Seong C; Cho KA; Lee SM; Kim TJ; Kim HJ; Cho JH; Jung W; Jang S; Shin JC; Lee KH; Byun JS; Kim DY
Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37144504
[TBL] [Abstract][Full Text] [Related]
2. Actein Antagonizes Oral Squamous Cell Carcinoma Proliferation through Activating FoxO1.
Zhao C; Zhang Z; Dai X; Wang J; Liu H; Ma H
Pharmacology; 2021; 106(9-10):551-563. PubMed ID: 34175854
[TBL] [Abstract][Full Text] [Related]
3. EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells.
Zheng M; Cao MX; Luo XJ; Li L; Wang K; Wang SS; Wang HF; Tang YJ; Tang YL; Liang XH
J Cell Mol Med; 2019 Oct; 23(10):6942-6954. PubMed ID: 31368152
[TBL] [Abstract][Full Text] [Related]
4. Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma.
Chen X; Liu Q; Chen Y; Wang L; Yang R; Zhang W; Pan X; Zhang S; Chen C; Wu T; Xia J; Cheng B; Chen X; Ren X
Mol Metab; 2022 Nov; 65():101600. PubMed ID: 36113774
[TBL] [Abstract][Full Text] [Related]
5. Spindle and kinetochore-associated complex 3 promotes cell growth via the PI3K/AKT/GSK3β and PI3K/AKT/FOXO1 pathways and is a potential prognostic biomarker for oral squamous cell carcinoma.
Xu H; Chen G; Niu Q; Song K; Feng Z; Han Z
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Nov; 134(5):599-614. PubMed ID: 36123287
[TBL] [Abstract][Full Text] [Related]
6. Transcription factor HBP1 is a direct anti-cancer target of transcription factor FOXO1 in invasive oral cancer.
Chan CY; Huang SY; Sheu JJ; Roth MM; Chou IT; Lien CH; Lee MF; Huang CY
Oncotarget; 2017 Feb; 8(9):14537-14548. PubMed ID: 28099936
[TBL] [Abstract][Full Text] [Related]
7. GATA6‑induced FN1 activation promotes the proliferation, invasion and migration of oral squamous cell carcinoma cells.
Zhai J; Luo G
Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35088888
[TBL] [Abstract][Full Text] [Related]
8. BST2 regulated by the transcription factor STAT1 can promote metastasis, invasion and proliferation of oral squamous cell carcinoma via the AKT/ERK1/2 signaling pathway.
Shan F; Shen S; Wang X; Chen G
Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36929425
[TBL] [Abstract][Full Text] [Related]
9. GAS5, a FoxO1-actived long noncoding RNA, promotes propofol-induced oral squamous cell carcinoma apoptosis by regulating the miR-1297-GSK3β axis.
Gao C; Ren C; Liu Z; Zhang L; Tang R; Li X
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3985-3993. PubMed ID: 31583913
[TBL] [Abstract][Full Text] [Related]
10. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
[TBL] [Abstract][Full Text] [Related]
11. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.
Prgomet Z; Axelsson L; Lindberg P; Andersson T
J Oral Pathol Med; 2015 Nov; 44(10):776-84. PubMed ID: 25459554
[TBL] [Abstract][Full Text] [Related]
12. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
[TBL] [Abstract][Full Text] [Related]
13. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY
J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832
[TBL] [Abstract][Full Text] [Related]
14. Investigating the role and mechanism of microRNA-196a in oral squamous cell carcinoma by targeting FOXO1.
Song H; Lai L; Liu M; Wang X; Zhang J; Zhang S
Exp Ther Med; 2020 Jun; 19(6):3707-3715. PubMed ID: 32346435
[TBL] [Abstract][Full Text] [Related]
15. LINC00664/miR-411-5p/KLF9 feedback loop contributes to the human oral squamous cell carcinoma progression.
Wang C; Wang Q; Weng Z
Oral Dis; 2023 Mar; 29(2):672-685. PubMed ID: 34582069
[TBL] [Abstract][Full Text] [Related]
16. RNAi-mediated downregulation of oral cancer overexpressed 1 (ORAOV1) inhibits vascular endothelial cell proliferation, migration, invasion, and tube formation.
Zhao X; Liu D; Wang L; Wu R; Zeng X; Dan H; Ji N; Jiang L; Zhou Y; Chen Q
J Oral Pathol Med; 2016 Apr; 45(4):256-61. PubMed ID: 26449957
[TBL] [Abstract][Full Text] [Related]
17. TOMM34 promotes cell proliferation, migration, and invasion of OSCC and modulates mitochondrial function.
Huang Y; Chen Z; Chen X; Chen X; Xu M
J Oral Pathol Med; 2023 Jan; 52(1):47-55. PubMed ID: 36367442
[TBL] [Abstract][Full Text] [Related]
18. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
19. Immunity-related long noncoding RNA WDFY3-AS2 inhibited cell proliferation and metastasis through Wnt/β-catenin signaling in oral squamous cell carcinoma.
Lin X; Ding JM; Zheng XZ; Chen JG
Arch Oral Biol; 2023 Mar; 147():105625. PubMed ID: 36657277
[TBL] [Abstract][Full Text] [Related]
20. FOXD1-AS1 upregulates FOXD1 to promote oral squamous cell carcinoma progression.
Ma Y; Han J; Luo X
Oral Dis; 2023 Mar; 29(2):604-614. PubMed ID: 34403535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
